OR-02

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOR-02
Drug Alias NameOrph-002small molecule (Orphazyme)Orph-2OR-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat-shock protein modulators
TargetsHeat-shock protein
Therapy Area/IndicationsNerve DegenerationLysosomal Storage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrphazyme A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrphazyme A/S
Active IndicationsN/A
Inactive IndicationsNerve DegenerationLysosomal Storage Diseases

Other Information

ATC CodeN/A
Related LinksN/A